SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Coral Laboratories - Quaterly Results

13 Feb 2025 Evaluate
A decent increase of about 27.15% in the sales to Rs. 229.86 millions was observed for the quarter ended December 2024. The sales figure stood at Rs. 180.78 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 184.97% to Rs. 61.44  millions  from Rs. 21.56 millions in previous same quarter.Operating Profit saw a handsome growth to 88.35 millions from 35.39 millions in the quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 229.86 180.78 27.15 868.71 547.74 58.60 836.60 781.18 7.09
Other Income 25.23 14.39 75.33 66.27 45.40 45.97 66.32 68.95 -3.81
PBIDT 88.35 35.39 149.65 301.82 145.30 107.72 228.71 107.07 113.61
Interest 0.19 0.00 0.00 0.58 0.00 0.00 0.00 3.38 -100.00
PBDT 88.16 34.67 154.28 301.24 144.58 108.36 227.07 104.07 118.19
Depreciation 5.02 4.91 2.24 15.05 14.73 2.17 19.76 21.80 -9.36
PBT 83.14 29.76 179.37 286.19 129.85 120.40 207.31 82.27 151.99
TAX 21.70 8.20 164.63 72.90 29.85 144.22 49.43 17.81 177.54
Deferred Tax 0.20 0.20 0.00 0.60 0.60 0.00 0.34 -0.39 -187.18
PAT 61.44 21.56 184.97 213.29 100.00 113.29 157.88 64.46 144.93
Equity 35.73 35.73 0.00 35.73 35.73 0.00 35.73 35.73 0.00
PBIDTM(%) 38.44 19.58 96.34 34.74 26.53 30.97 27.34 13.71 99.46

Coral Laboratories Share Price

421.20 7.90 (1.91%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×